Intra-Cellular Therapies to Participate in Three Upcoming Investor Conferences

Article Stock Quotes (1)

FREE Breaking News Alerts from StreetInsider.com!

StreetInsider.com Top Tickers, 9/11/2026

1. ORCL
2. ADBE
3. RH
4. SPY
5. CPRT

6. ACVA
7. SEDG
8. TLT
9. PMTS
10. QQQ

Get Alerts ITCI Hot Sheet

Price: $131.87 --0%

Overall Analyst Rating:
SELL (= Flat)

Join SI Premium – FREE

NEW YORK, March 06, 2024 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced that it will participate in three upcoming investor conferences:

Leerink Partners Global Biopharma ConferenceTuesday, March 12, 2024 at 10:40 a.m. ET in Miami, FL

Jefferies Biotech on the Bay Summit Wednesday, March 13, 2024 in Miami, FL

UBS Virtual CNS DayMonday, March 18, 2024

A live and achieved webcast of the Company’s presentation at the Leerink Partners Global Biopharma Conference can be accessed under "Events & Presentations" in the Investor Relations section of the Company's website at www.intracellulartherapies.com. Please log in approximately 5-10 minutes prior to the event to register and to download and install any necessary software.

About Intra-Cellular Therapies

Intra-Cellular Therapies is a biopharmaceutical company founded on Nobel prize-winning research that allows us to understand how therapies affect the inner-workings of cells in the body. The company leverages this intracellular approach to develop innovative treatments for people living with complex psychiatric and neurologic diseases. For more information, please visit www.intracellulartherapies.com.

Contact:

Intra-Cellular Therapies, Inc.Juan Sanchez, M.D. Vice President, Corporate Communications and Investor Relations646-440-9333

Burns McClellan, Inc.Cameron Radinovic[email protected]212-213-0006